Mitrano Richard J.'s Form 4/A amendment
AmendedKorro Bio, Inc. (KRRO) · filed Jul 12, 2023
- Accession no.
- 0000950170-23-032740
- Filed
- Jul 12, 2023, 9:25 PM ET
- Trade date
- Jul 7-10, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Jul 11, 2023
This filing lists 2 non-derivative transactions. It carries over 4 transactions from the original filing that it did not restate. Open-market sales total $160.6. It was filed 5 days after the trade.
This amendment restates part of 0001127602-23-020572 (filed Jul 11, 2023). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mitrano Richard J.CIK 0001785287 | Officer (VP Finance & Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 7, 2023 | Common Stock | SSaleDisposed | −220 | $0.36F2 | −$79.2 | 55,551 | Direct | |
| Jul 10, 2023 | Common Stock | SSaleDisposed | −220 | $0.37 | −$81.4 | 55,331 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001127602-23-020572 (filed Jul 11, 2023).
Non-derivative securities (Table I)
Derivative securities (Table II)
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F3
Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
- F2
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.35 to $0.36. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Referenced by the price of 1 transaction in Table I.
Remarks
This Form 4/A is being filed to remove the vesting of the Restricted Stock Units in Table I and Table II and to correct the aggregate securities following the transaction in column 5 of Table I.